AIMS/HYPOTHESIS: Recent studies have revealed that MHC-linked susceptibility to Type 1 diabetes is determined by multiple components. In the non-obese diabetic (NOD) mouse, a second component (Idd16) has been mapped to a region adjacent to, but distinct from Idd1 in the class II region. In this study, we investigated the class I K gene as a candidate gene for Idd16. METHODS: We determined the genomic sequences of the class I K gene as well as the reactivity of K molecules with monoclonal antibodies in the NOD mouse, the Cataract Shionogi (CTS) mouse, and the NOD.CTS-H-2 congenic strain, which possesses a resistance allele to Type 1 diabetes at the Idd16 on the NOD genetic background genes. RESULTS: While the K sequence of the NOD mouse was identical to that of Kd type, ten nucleotide substitutions were identified in the CTS mouse compared with the NOD mouse. Of these, three were in exon 4, giving two amino acid substitutions, which were identical to those seen in KK type. These characteristics were retained in the NOD.CTS-H-2 congenic strain, which had a lower incidence and delayed onset of Type 1 diabetes owing to a resistance allele at Idd16. Lymphocytes from NOD.CTS-H2 congenic mice reacted with anti-Kd and anti-Kk monoclonal antibodies, reflecting the unique sequence of the K gene. The nucleotide sequence of the K gene in the non-obese non-diabetic (NON) mouse was also unique, consisting of a combination of Kk- and Kb-like sequences. CONCLUSIONS/ INTERPRETATION: These data suggest that H2-K is unique in CTS and NON mice, and that allelic variation of the class I K gene may be responsible for Idd16.
AIMS/HYPOTHESIS: Recent studies have revealed that MHC-linked susceptibility to Type 1 diabetes is determined by multiple components. In the non-obese diabetic (NOD) mouse, a second component (Idd16) has been mapped to a region adjacent to, but distinct from Idd1 in the class II region. In this study, we investigated the class I K gene as a candidate gene for Idd16. METHODS: We determined the genomic sequences of the class I K gene as well as the reactivity of K molecules with monoclonal antibodies in the NOD mouse, the Cataract Shionogi (CTS) mouse, and the NOD.CTS-H-2 congenic strain, which possesses a resistance allele to Type 1 diabetes at the Idd16 on the NOD genetic background genes. RESULTS: While the K sequence of the NOD mouse was identical to that of Kd type, ten nucleotide substitutions were identified in the CTS mouse compared with the NOD mouse. Of these, three were in exon 4, giving two amino acid substitutions, which were identical to those seen in KK type. These characteristics were retained in the NOD.CTS-H-2 congenic strain, which had a lower incidence and delayed onset of Type 1 diabetes owing to a resistance allele at Idd16. Lymphocytes from NOD.CTS-H2 congenic mice reacted with anti-Kd and anti-Kk monoclonal antibodies, reflecting the unique sequence of the K gene. The nucleotide sequence of the K gene in the non-obese non-diabetic (NON) mouse was also unique, consisting of a combination of Kk- and Kb-like sequences. CONCLUSIONS/ INTERPRETATION: These data suggest that H2-K is unique in CTS and NON mice, and that allelic variation of the class I K gene may be responsible for Idd16.
Authors: T Lund; L O'Reilly; P Hutchings; O Kanagawa; E Simpson; R Gravely; P Chandler; J Dyson; J K Picard; A Edwards Journal: Nature Date: 1990-06-21 Impact factor: 49.962
Authors: H Ikegami; S Makino; E Yamato; Y Kawaguchi; H Ueda; T Sakamoto; K Takekawa; T Ogihara Journal: J Clin Invest Date: 1995-10 Impact factor: 14.808
Authors: Theresa A Aly; Akane Ide; Mohamed M Jahromi; Jennifer M Barker; Maria S Fernando; Sunanda R Babu; Liping Yu; Dongmei Miao; Henry A Erlich; Pamela R Fain; Katherine J Barriga; Jill M Norris; Marian J Rewers; George S Eisenbarth Journal: Proc Natl Acad Sci U S A Date: 2006-09-11 Impact factor: 11.205
Authors: Mary A Yui; Ni Feng; Jingli A Zhang; Chen Yee Liaw; Ellen V Rothenberg; Jeffrey A Longmate Journal: J Immunol Date: 2013-02-25 Impact factor: 5.422
Authors: Daniel R Brims; Jie Qian; Irene Jarchum; Leann Mikesh; Edith Palmieri; Udupi A Ramagopal; Vladimir N Malashkevich; Rodolfo J Chaparro; Torben Lund; Masakazu Hattori; Jeffrey Shabanowitz; Donald F Hunt; Stanley G Nathenson; Steven C Almo; Teresa P Dilorenzo Journal: Int Immunol Date: 2010-01-21 Impact factor: 4.823
Authors: Marta Luna-Sánchez; Elena Díaz-Casado; Emanuele Barca; Miguel Ángel Tejada; Ángeles Montilla-García; Enrique Javier Cobos; Germaine Escames; Dario Acuña-Castroviejo; Catarina M Quinzii; Luis Carlos López Journal: EMBO Mol Med Date: 2015-05 Impact factor: 12.137